all-trans-retinol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on expanded Disability Status Scale (EDSS)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“There were no significant differences between the "Mean ± SD" of EDSS changes in the treated (0.07 ± 0.23) and placebo (0.08 ± 0.23) groups (P = 0.73).”
Quoted verbatim from Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis.. - Study
- RCT
- Duration
- 12 months
- Dose
- retinyl palmitate 25000 IU/d for six months then 10000 IU/d for six months
- Population
- Patients with relapsing-remitting multiple sclerosis in a 1-year placebo-controlled trial
Impact of Vitamin A Supplementation on Disease Progression in Patients with Multiple Sclerosis.2015PMID:26161708Permalink
Keep reading
- Everything the graph holds on all-trans-retinol
- Every compound studied against Expanded Disability Status Scale (EDSS)
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5MC9XH4P293J6CA5986BF3J